IKS - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.0
| Stock Code | IKS | Market Cap | 28,405 Cr. | Current Price | 1,655 ₹ | High / Low | 1,876 ₹ |
| Stock P/E | 57.1 | Book Value | 86.2 ₹ | Dividend Yield | 0.00 % | ROCE | 35.0 % |
| ROE | 32.3 % | Face Value | 1.00 ₹ | DMA 50 | 1,474 ₹ | DMA 200 | 1,561 ₹ |
| Chg in FII Hold | 0.63 % | Chg in DII Hold | 0.34 % | PAT Qtr | 146 Cr. | PAT Prev Qtr | 138 Cr. |
| RSI | 72.3 | MACD | 36.7 | Volume | 13,79,367 | Avg Vol 1Wk | 7,64,435 |
| Low price | 1,262 ₹ | High price | 1,876 ₹ | PEG Ratio | 3.29 | Debt to equity | 0.07 |
| 52w Index | 64.0 % | Qtr Profit Var | 76.7 % | EPS | 29.0 ₹ | Industry PE | 26.0 |
Financials: IKS demonstrates strong fundamentals with ROCE at 35.0% and ROE at 32.3%. EPS of ₹29.0 supports profitability, while quarterly PAT improved to ₹146 Cr. from ₹138 Cr. Debt-to-equity ratio of 0.07 indicates financial stability.
Valuation: P/E of 57.1 is significantly above industry average (26.0), suggesting premium valuation. PEG ratio of 3.29 highlights stretched growth-adjusted pricing. Dividend yield is nil, limiting income appeal.
Business Model: IKS operates with strong competitive positioning, leveraging efficiency and growth in its sector. Institutional inflows (FII +0.63%, DII +0.34%) reflect confidence.
Entry Zone: Reasonable entry between ₹1,450–₹1,550 near DMA 50 (₹1,474) and DMA 200 (₹1,561). Long-term holding favorable if earnings growth sustains, though valuation remains expensive.
Positive
- Strong ROCE (35.0%) and ROE (32.3%) highlight efficient capital use
- EPS of ₹29.0 supports valuation strength
- Low debt-to-equity ratio (0.07) ensures financial stability
- Sequential PAT improvement shows earnings momentum
- Institutional inflows (FII +0.63%, DII +0.34%) add confidence
Limitation
- High P/E (57.1) compared to industry average (26.0) indicates overvaluation
- PEG ratio of 3.29 reflects limited growth-adjusted value
- RSI at 72.3 signals overbought conditions
- Dividend yield of 0.00% reduces investor income appeal
Company Negative News
- Valuation stretched relative to peers
- Overbought RSI increases risk of correction
Company Positive News
- Quarterly PAT improved from ₹138 Cr. to ₹146 Cr.
- Positive MACD (36.7) supports bullish momentum
- Institutional inflows show investor confidence
Industry
- Sector outlook remains positive with growth opportunities
- Industry P/E at 26.0 highlights IKS trading at premium valuation
Conclusion
IKS is fundamentally strong with high ROE/ROCE, low debt, and improving profitability. However, stretched valuations and overbought technicals limit upside in the near term. Entry around ₹1,450–₹1,550 offers a balanced risk-reward, but long-term investors should monitor valuation compression and earnings sustainability.
Would you like me to also prepare a swing-trade HTML module for IKS with entry/exit levels, stop-loss, and momentum overlays, so you can integrate it alongside this fundamental view in your workflow library?